Cancer Drug Resistance

Edit Your Profile

Cancer Drug Resistance Journal

publication venue for

Using cfRNA as a tool to evaluate clinical treatment outcomes in patients with metastatic lung cancers and other tumors. 4:1061-1071. 2021
Proteasomal adaptations to FDA-approved proteasome inhibitors: A potential mechanism for drug resistance? 2021

Electronic International Standard Serial Number (EISSN)

2578-532X